We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Stockholm, Sweden

ESTRO 2026

Session

CNS
Digital Poster
Clinical
Repeat Radiosurgery for Pituitary Adenomas: A Systematic Review and Meta-Analysis of Efficacy and Safety
Fatemeh Jafari, Iran Islamic Republic of
-247
Clinical outcomes of moderately hypofractionated stereotactic radiotherapy for meningiomas
DAICHI TORIZUKA, Japan
-608
Evaluating Optimal Dose and Field of Radiation Therapy in Pineal Parenchymal Tumors of Intermediate Differentiation (PPTID): A Retrospective Study
Ammar Salkini, Canada
-749
Dose-escalated Proton Beam Therapy in base of skull chordoma and chondrosarcomas: a single institute's analysis of dosimetry and outcomes
Mithushanaa Nesarajah, United Kingdom
-841
Reirradiation outcomes in patients with recurrent glioblastoma treated with either hypofractionated or conventionally fractionated radiation therapy
Lindsey Sloan, USA
-1267
Stereotactic Radiosurgery for Skull-base Paragangliomas: Clinical & Biochemical Outcomes from a Tertiary UK centre
Soirindhri Banerjee, United Kingdom
-1724
Balancing toxicity and control: lesion-based analysis of radionecrosis and dosimetry after Gamma Knife with immunotherapy and targeted therapy
Zineb Belbaraka, Belgium
-1911
Postoperative adjuvant radiotherapy for intracranial WHO Grade II meningiomas: monoinstitutional experience with VMAT hypofractionated schedules
Patrizia Massaro, Italy
-2021
Benchmarking the impact of maximal treatment on real-world survival of glioblastoma patients for future trials of novel local treatments.
Sarah Kingdon, United Kingdom
-2076
Local control after stereotactic radiosurgery and fractionated stereotactic radiotherapy for cerebellopontine angle tumours
Łukasz Raszewski, Poland
-2228
Leptomeningeal Dissemination in High-Grade Glial Tumours: Incidence, Risk Factors and Survival Outcomes
SERRA KAMER, Turkey
-2809
Comparing MR and PET recurrence volumes and patterns of failure for a phase II glioblastoma clinical trial of 18F-DOPA-PET directed dose escalated RT
Debra Brinkmann, USA
-3002
Initial experience with adaptive MR-linac radiotherapy for high-grade gliomas: tolerability and volume dynamics
Alonso La Rosa de los Ríos, Spain
-3064
Survival after normofractionated re-irradiation for recurrent glioblastoma - a retrospective analysis from the Comprehensive Cancer Center Vienna
Vincent Dick, Austria
-3234
Feasibility of Margin Reduction to the Pseudocapsule Border in Fractionated Stereotactic Radiotherapy of Acoustic Neuroma: First Three-Year Evaluation
Gyöngyi Kelemen, Hungary
-3339
SRS for Vestibular Schwannoma: Impact of Treatment Time Differences on the Biologically Effective Dose - Gamma Knife, Cyberknife and Truebeam Compared
Matthew Skinner, USA
-3637
Diffuse 5-Aminolevulinic acid (5-ALA) Residual Fluorescence Predicts Worse Survival in Glioblastoma Multiforme
Gopikrishna Shyam, United Kingdom
-3741
Proton radiotherapy for recurrent or residual pituitary adenoma: A retrospective, single center experience.
Fabian Allmendinger, Germany
-3834
Robotic gyroscopic lattice radiotherapy for recurrent or progressive high-grade gliomas: The largest secondary re-irradiation cohort to date
Gozde Yazici, Turkey
-3871
A Simplified Three-Factor Prognostic Score for IDH-Wildtype Glioblastoma in the Molecular Era
Akihito Okubo, Japan
-3892
Diagnostic challenges in differentiating early and late postradiation changes from tumor progression in brain neoplasms: impact on treatment decisions
Olga Silaieva, Ukraine
-3896
Oncological value of MRI in brain metastasis: Combining post-contrast SPACE and MPRAGE for stereotactic radiosurgery planning and follow-up
Ekin Ermis, Switzerland
-4042
Standard biological equivalent dose hypofractionated radiotherapy for glioblastoma elderly or frail patients
Roberta MUNI, Italy
-4673
Patterns of recurrence and local control in WHO grade 2 meningiomas according to radiotherapy modality: a retrospective institutional analysis
Irving Efraín Sánchez Rodríguez, Mexico
-4771
Benign brain tumors' response to radiotherapy: a retrospective study
Angie Yurani Ramos de los Ríos, Spain
-4957
Radiotherapy Utilization in Central Nervous System Tumours: An Institutional Experience from sub-Saharan Africa
Adedayo Joseph, Nigeria
-5031
Identification of LFNG as a Novel Autonomous Predictive Gene for Resistance to Radiotherapy in Glioblastoma Patients
Asmaa NAIM, Morocco
-5095
Focal conformal radiotherapy plus adjuvant chemotherapy in low-risk WNT-MB: long-term and mature outcomes from a prospective de-intensification study
Tejpal Gupta, India
-5219